Study on Rapid Immune Modulating Effects

This study is looking at how quickly a special nutritional blend affects your immune cells. We are comparing a "Nutraceutical blend" (made from cow colostrum, mushroom extracts, and vitamin C) with a "Placebo" (four capsules with no active ingredients). The goal is to see if the nutraceutical blend can quickly improve your immune cell surveillance, which is how your body watches for and responds to threats. We'll measure this effect within 3 hours after you take the product. We are looking for 24 healthy adults, aged 18 to 75, who have easily visible veins for blood draws and are willing to follow specific diet and lifestyle routines during the study. The current recruitment status is unclear.

Study design
This is a double-blind, placebo-controlled, cross-over study with 24 participants. This means neither you nor the study staff will know if you're receiving the Nutraceutical blend or the Placebo, and you will receive both at different times.
What's involved
You will have blood samples taken at baseline, and then 1, 2, and 3 hours after consuming a test product. You will also need to maintain a consistent diet and lifestyle, eat bland breakfasts on clinic visit days, and avoid exercise and certain nutritional items.
Compensation
Not stated in the trial record.
Follow-up
Your immune cell surveillance will be measured at 3 hours after consuming a test product.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07206407

Clinical Trial on Rapid Immune Modulating Effects

Recruiting
NAAges 18–75InterventionalBasic science
Natural Immune Systems Inc
~24 participants
Updated 2025-12-17 on ClinicalTrials.gov
What's tested:PlaceboNutraceutical blend

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Immune cell surveillance
Measured over 3 hours after consuming a test product for this study protocol
Immune Surveillance
1 sites across 1 states
Oregon1
  • Gitte S. Jensen, PhD · PRINCIPAL_INVESTIGATOR · NIS Labs

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Healthy adults;
Age 18-75 years (inclusive);
Veins easy to see in one or both arms (to allow for the multiple blood draws);
Willing to comply with study procedures, including:
Maintaining a consistent diet and lifestyle routine throughout the study,
Consistent habit of bland breakfasts on days of clinic visits,
Abstaining from exercising and nutritional supplements on the morning of a study visit,
Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit;
Abstaining from music, candy, gum, computer/cell phone use, during clinic visits.

Exclusion

Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder);
Taking anti-inflammatory medications on a daily basis;
Currently experiencing intense stressful events/ life changes;
Currently in intensive athletic training (such as marathon runners);
Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel;
An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying);
Unwilling to maintain a constant intake of supplements over the duration of the study;
Anxiety about having blood drawn;
Pregnant, nursing, or trying to become pregnant;
Known allergies related to ingredients in active test product or placebo.
  • Immune cell surveillance3 hours after consuming a test product for this study protocol

    Observation of changes in immune cell trafficking, i.e., the changes in immune cell numbers in the peripheral blood following administration. Data is collected as 'cell numbers per uL whole blood' for the following immune cell types: * Monocytes * NK cells * NKT cells * T cells * non-NK nonT cells